Discover how Chemycal PRO helps you boosting your regulatory monitoring:
The drug is oxybutynin, or Ditropan XL, long used to treat urinary incontinence.
The study found that women taking the medicine had an average of five fewer hot flashes a week, compared with three fewer among women taking a placebo.
"Oxybutynin is an option that can control these symptoms and improve quality of life," said lead researcher Dr. Roberto Leon-Ferre, an assistant professor of oncology at the Mayo Clinic in Rochester, Minn.
CONTINUE READING ON www.upi.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions